Navigation Links
Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting
Date:6/5/2009

Akaza Research CEO will be presenting at the upcoming DIA annual meeting. In addition, Akaza Research will be be exhibiting OpenClinica, the popular open source clinical trials software.

Cambridge, MA (PRWEB) June 5, 2009 -- Akaza Research is pleased to announce that Chief Executive Officer Cal Collins will deliver a presentation at the Drug Information Association's (DIA's) 45th Annual Meeting, June 21-25, in San Diego, CA. The session, titled "Utilizing and Integrating Open Source Software in Clinical Research Environments," will explore how open source, standards-based software can improve flexibility, interoperability, and cost in clinical trials.

At the event Akaza Research will also be exhibiting OpenClinica, its flagship open source clinical trials software product for electronic data capture (EDC) and clinical data management in. Personnel from Akaza Research will be on-hand to demonstrate OpenClinica and answer questions.

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates data collection via electronic case report forms (eCRFs), and provides tools for data management and productive monitoring of clinical trials. OpenClinica supports leading CDISC standards and is designed to be compliant with industry and government regulations and guidelines such as 21 CFR Part 11, GCP, and HIPAA. OpenClinica is professionally supported by Akaza Research and has a worldwide open source community of over 6,000 users and developers. All versions of OpenClinica are freely available for download and use from http://www.openclinica.org.

About Akaza Research®

Akaza Research provides professional open source software for clinical trials. The company's flagship product, OpenClinica, provides electronic data capture (EDC) and clinical data management (CDM) capabilities for clinical research. By bringing open source software into the mainstream of clinical research, Akaza is able to provide a cost effective technology solution that is more flexible and transparent than proprietary, closed systems. Akaza Research provides a full spectrum of OpenClinica-related products and services to a worldwide customer base through its OpenClinica EnterpriseTM solution. For more information about Akaza Research, see http://www.akazaresearch.com.

# # #

Read the full story at http://www.prweb.com/releases/openclinica/clinical-trials-software/prweb2496654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
2. Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
6. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
7. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
8. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
9. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12, 2016  BD (Becton, Dickinson and Company) (NYSE: ... today announced the launch of the BD CLiC™ System ... (AGBT) Meeting. --> ... by providing cost effective NGS library preparation with limited ... fully integrated, next generation sequencing (NGS) library prep instrument, ...
(Date:2/11/2016)... DIEGO, Feb. 11, 2016  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... ended December 31, 2015. --> ... a net loss of $29.3 million, or $0.34 loss per share, ... per share for the same period in 2014. For the year ... $88.9 million, or $1.05 loss per share, as compared to a ...
(Date:2/11/2016)... ATLANTA , Feb. 11, 2016  Spectra BioPharma ... Organization (CSO) that provides biopharma companies the experience, ... implement and deploy outsourced sales teams. Created in ... team addresses both the strategic and tactical needs ... innovative sales solutions through both personal and non-personal ...
(Date:2/11/2016)... BEACH, Florida , February 11, 2016 /PRNewswire/ ... PositiveID Corporation ("PositiveID" or "Company") (OTCQB: PSID), ... diagnostics, announced today that its Thermomedics subsidiary, which ... progress on its growth plan in January 2016, ... products distributors, increasing sequential monthly sales growth, and ...
Breaking Biology Technology:
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/3/2016)... , Feb. 3, 2016 Vigilant Solutions ... Police Department in Missouri solved ... plate reader (LPR) data from Vigilant Solutions. ... case in which the victim was walking out of a convenience store and ... space next to his vehicle, striking his vehicle and ...
(Date:2/2/2016)... , Feb. 2, 2016 Checkpoint ... that Rising Market Are you interested in ... forecasts revenues for checkpoint inhibitors. Visiongain,s report gives ... submarket, product and national level. Avoid falling ... what progress, opportunities and revenues those emerging cancer ...
Breaking Biology News(10 mins):